Related references
Note: Only part of the references are listed.Racial Disparities in Access to Prostate Cancer Clinical Trials: A County-Level Analysis
Wei-Jhih Wang et al.
JNCI CANCER SPECTRUM (2022)
Race/Ethnicity and County-Level Social Vulnerability Impact Hospice Utilization Among Patients Undergoing Cancer Surgery
Alizeh Abbas et al.
ANNALS OF SURGICAL ONCOLOGY (2021)
Older adult participation in cancer clinical trials: A systematic review of barriers and interventions
Mina S. Sedrak et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Disparities in treatment patterns and outcomes among younger and older adults with newly diagnosed multiple myeloma: A population-based study
Hira S. Mian et al.
JOURNAL OF GERIATRIC ONCOLOGY (2021)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Social Vulnerability and Premature Cardiovascular Mortality Among US Counties, 2014 to 2018
Safi U. Khan et al.
CIRCULATION (2021)
High Social Vulnerability and Textbook Outcomes after Cancer Operation
J. Madison Hyer et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2021)
Association of County-Level Vulnerability, Patient-Level Race/Ethnicity, and Receipt of Surgery for Early-Stage Hepatocellular Carcinoma
[Anonymous]
JAMA SURGERY (2021)
Integrating Research into Community Practice - Toward Increased Diversity in Clinical Trials
Janet Woodcock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Spatial Inequities in COVID-19 Testing, Positivity, Confirmed Cases, and Mortality in 3 US Cities An Ecological Study
Usama Bilal et al.
ANNALS OF INTERNAL MEDICINE (2021)
Persistent Disparity: Socioeconomic Deprivation and Cancer Outcomes in Patients Treated in Clinical Trials
Joseph M. Unger et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Spatial and temporal trends in social vulnerability and COVID-19 incidence and death rates in the United States
Brian Neelon et al.
PLOS ONE (2021)
Association of social vulnerability with the use of high-volume and Magnet recognition hospitals for hepatopancreatic cancer surgery
Adrian Diaz et al.
SURGERY (2021)
Evaluation of Community-Level Vulnerability and Racial Disparities in Living Donor Kidney Transplant
A. Cozette Killian et al.
JAMA SURGERY (2021)
Neighborhood socioeconomic disadvantage is associated with multimorbidity in a geographically-defined community
Alanna M. Chamberlain et al.
BMC PUBLIC HEALTH (2020)
Association of Patient Demographic Characteristics and Insurance Status With Survival in Cancer Randomized Clinical Trials With Positive Findings
Joseph M. Unger et al.
JAMA NETWORK OPEN (2020)
County-Level Association of Social Vulnerability with COVID-19 Cases and Deaths in the USA
Rohan Khazanchi et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2020)
Neighborhood-LevelSocial Disadvantage and Risk of Delirium Following Major Surgery
Franchesca Arias et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2020)
Representativeness of Black Patients in Cancer Clinical Trials Sponsored by the National Cancer Institute Compared With Pharmaceutical Companies
Joseph M. Unger et al.
JNCI CANCER SPECTRUM (2020)
Factors Associated With Age Disparities Among Cancer Clinical Trial Participants
Ethan B. Ludmir et al.
JAMA ONCOLOGY (2019)
Using the Social Vulnerability Index to Examine Local Disparities in Emergent and Elective Cholecystectomy
Heather Carmichael et al.
JOURNAL OF SURGICAL RESEARCH (2019)
Making Neighborhood-Disadvantage Metrics Accessible - The Neighborhood Atlas
Amy J. H. Kind et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Representation of Minorities and Women in Oncology Clinical Trials: Review of the Past 14 Years
Narjust Duma et al.
JOURNAL OF ONCOLOGY PRACTICE (2018)
Geographic Distribution and Survival Outcomes for Rural Patients With Cancer Treated in Clinical Trials
Joseph M. Unger et al.
JAMA NETWORK OPEN (2018)
Barriers to Clinical Trial Enrollment in Racial and Ethnic Minority Patients With Cancer
Lauren M. Hamel et al.
CANCER CONTROL (2016)
Patient Income Level and Cancer Clinical Trial Participation: A Prospective Survey Study
Joseph M. Unger et al.
JAMA ONCOLOGY (2016)
Geographic Accessibility to Clinical Trials for Advanced Cancer in the United States
Matthew D. Galsky et al.
JAMA INTERNAL MEDICINE (2015)
Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers Results From the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010
Chenjie Zeng et al.
JAMA ONCOLOGY (2015)
Racial/Ethnic Differences in Clinical Trial Enrollment, Refusal Rates, Ineligibility, and Reasons for Decline Among Patients at Sites in the National Cancer Institute's Community Cancer Centers Program
Aisha T. Langford et al.
CANCER (2014)
Effect of Patient Socioeconomic Status on Access to Early-Phase Cancer Trials
Aisyah Mohd Noor et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Under-Representation of Older Adults in Cancer Registration Trials: Known Problem, Little Progress
Kevin S. Scher et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Analysis of Maryland Cancer Patient Participation in National Cancer Institute-Supported Cancer Treatment Clinical Trials
Claudia R. Baquet et al.
JOURNAL OF HEALTH CARE FOR THE POOR AND UNDERSERVED (2009)
Quasi-poisson vs. negative binomial regression: How should we model overdispersed count data?
Jay M. Ver Hoef et al.
ECOLOGY (2007)
Enrollment of elderly patients in clinical trials for cancer drug registration: A 7-year experience by the US Food and Drug Administration
L Talarico et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Participation in cancer clinical trials - Race-, sex-, and age-based disparities
VH Murthy et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials
WB Sateren et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Participation of minorities in cancer research: The influence of structural, cultural, and linguistic factors
AR Giuliano et al.
ANNALS OF EPIDEMIOLOGY (2000)